HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gether, U. Articles by Schwartz, T. W. Search for Related Content PubMed PubMed Citation Articles by Gether, U. Articles by Schwartz, T. W. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 39, 23959-23964, Sep, 1994

Specific residues at the top of transmembrane segment V and VI of the neurokinin-1 receptor involved in binding of the nonpeptide antagonist CP 96,345 [corrected] [published erratum appears in J Biol Chem 1994 Dec 23;269(51):32708]

U Gether, L Nilsson, JA Lowe 3rd and TW Schwartz
University Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.

Previously we have found that binding of the nonpeptide substance P antagonist, CP 96,345, to the neurokinin-1 (NK-1) receptor was critically dependent on two short segments adjacent to the top of transmembrane segments (TM) V and VI, called segments A (residues 183- 195) and D (residues 271-276), respectively. In the present study we have systematically performed substitutions of nonconserved residues within these two segments with residues from the homologous NK-3 and/or NK-2 receptor. In segment A, deletion of residues Glu193 and Lys194, which are not present in the NK-3 receptor, or substituting them with leucines as in the NK-2 receptor, decreased the affinity of CP 96,345 10- and 22-fold, respectively. Surprisingly, switching the position of Glu193 and Lys194 did not affect the affinity of CP 96,345, suggesting that, rather than interacting directly with CP 96,345, an interaction of these residues with one another is important for CP 96,345 binding. In segment D substitution of Tyr272 with threonine as in the NK-2 receptor and with alanine as in the NK-3 receptor decreased the affinity of CP 96,345 7- and 24-fold, respectively. Mutation of the preceding Pro271 to glycine alone did not affect CP 96,345 binding, but, combined with the mutation of Tyr272 to threonine, the affinity decreased 28-fold. A series of CP 96,345 analogues with modifications of the major chemical moieties exhibited equally reduced affinity as that of CP 96,345 for the Tyr272- and Lys193-Glu194-substituted constructs, except CP 95,555, which lacks one of the phenyl rings in the benzhydryl group and which was almost unaffected by these mutations. In conclusion, our data indicate a direct interaction between CP 96,345 and Tyr272, which are located at the top of TM VI likely in close spatial proximity to the previously identified interaction point, His197, at the top of the adjacent TM V. Furthermore, the data demonstrated a critical involvement in CP 96,345 binding of Lys193 and Glu194 located one alpha-helical turn above His197.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. F. Tansky, C. Pothoulakis, and S. E. Leeman Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor PNAS, June 19, 2007; 104(25): 10691 - 10696. [Abstract] [Full Text] [PDF]

				U. Gether Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors Endocr. Rev., February 1, 2000; 21(1): 90 - 113. [Abstract] [Full Text]

				X.-P. Huang, F. E. Williams, S. M. Peseckis, and W. S. Messer Jr. Differential Modulation of Agonist Potency and Receptor Coupling by Mutations of Ser388Tyr and Thr389Pro at the Junction of Transmembrane Domain VI and the Third Extracellular Loop of Human M1 Muscarinic Acetylcholine Receptors Mol. Pharmacol., October 1, 1999; 56(4): 775 - 783. [Abstract] [Full Text]

				V. Gigoux, C. Escrieut, J.-A. Fehrentz, S. Poirot, B. Maigret, L. Moroder, D. Gully, J. Martinez, N. Vaysse, and D. Fourmy Arginine 336 and Asparagine 333 of the Human Cholecystokinin-A Receptor Binding Site Interact with the Penultimate Aspartic Acid and the C-terminal Amide of Cholecystokinin J. Biol. Chem., July 16, 1999; 274(29): 20457 - 20464. [Abstract] [Full Text] [PDF]

				O. Dery, C. U. Corvera, M. Steinhoff, and N. W. Bunnett Proteinase-activated receptors: novel mechanisms of signaling by serine proteases Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1429 - C1452. [Abstract] [Full Text] [PDF]

				B. Holst, S. Zoffmann, C. E. Elling, S. A. Hjorth, and T. W. Schwartz Steric Hindrance Mutagenesis versus Alanine Scan in Mapping of Ligand Binding Sites in the Tachykinin NK1 Receptor Mol. Pharmacol., January 1, 1998; 53(1): 166 - 175. [Abstract] [Full Text] [PDF]

				G. Turcatti, S. Zoffmann, J. A. Lowe III, S. E. Drozda, G. Chassaing, T. W. Schwartz, and A. Chollet Characterization of Non-peptide Antagonist and Peptide Agonist Binding Sites of the NK1 Receptor with Fluorescent Ligands J. Biol. Chem., August 22, 1997; 272(34): 21167 - 21175. [Abstract] [Full Text] [PDF]

				J. H. Perlman, A.-O. Colson, W. Wang, K. Bence, R. Osman, and M. C. Gershengorn Interactions between Conserved Residues in Transmembrane Helices 1, 2, and 7 of the Thyrotropin-releasing Hormone Receptor J. Biol. Chem., May 2, 1997; 272(18): 11937 - 11942. [Abstract] [Full Text] [PDF]

				K. Thirstrup, C. E. Elling, S. A. Hjorth, and T. W. Schwartz Construction of a High Affinity Zinc Switch in the kappa-Opioid Receptor J. Biol. Chem., April 5, 1996; 271(14): 7875 - 7878. [Abstract] [Full Text] [PDF]